Range
8.04 - 8.35
Vol / Avg.
34.3K/77.2K
Div / Yield
-
52 Wk
6.61 - 14.31
Mkt Cap
342.6M
Payout Ratio
-
Open
8.2
P/E
-
EPS
-0.42
Shares
42.5M
Outstanding
42.5M
Total Float
41.9M
load more
Sector: Health Care.Industry: Biotechnology
Fusion Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing alpha therapeutics for curing cancer. It develops Targeted Alpha Therapies (TAT) together with its proprietary Fast-Clear linker technology. The firm's lead product candidate comprises FPI-1434, a monotherapy for the treatment of a variety of cancers; FPI-1966, for the treatment of head and neck and bladder cancers; and FPI-2059 among others.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS-0.420
REV0
Q4 2020Est.ActualSurprise
EPS-0.320
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
FUSNFusion Pharmaceuticals-1.94%342.6M

Fusion Pharmaceuticals Frequently Asked Questions

Q

How do I buy Fusion Pharmaceuticals (FUSN) stock?

A

You can purchase shares of Fusion Pharmaceuticals (NASDAQ: FUSN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Fusion Pharmaceuticals's (FUSN) competitors?

Q

What is the target price for Fusion Pharmaceuticals (FUSN) stock?

A

The latest price target for Fusion Pharmaceuticals (NASDAQ: FUSN) was reported by Morgan Stanley on May 18, 2021. The analyst firm set a price target for 20.00 expecting FUSN to rise to within 12 months (a possible 147.83% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Fusion Pharmaceuticals (FUSN)?

A

The stock price for Fusion Pharmaceuticals (NASDAQ: FUSN) is $8.07 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Fusion Pharmaceuticals (FUSN) pay a dividend?

A

There are no upcoming dividends for Fusion Pharmaceuticals.

Q

When is Fusion Pharmaceuticals (NASDAQ:FUSN) reporting earnings?

A
Fusion Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 10, 2021.
Q

Is Fusion Pharmaceuticals (FUSN) going to split?

A

There is no upcoming split for Fusion Pharmaceuticals.

Q

What sector and industry does Fusion Pharmaceuticals (FUSN) operate in?

A

Fusion Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.